Ditropan Oral Tablet 5Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • myWeekly Ad

Ditropan: Oral tablet (5mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file DrugItem_460.JPG
Ditropan 5mg Tab
Sanofi-Aventis US LLC
Pill Identification: DITROPAN  |  92 00
Drug Image file DrugItem_1934.JPG
Oxybutynin 5mg Tab
Upsher-Smith Laboratories, Inc
Pill Identification: 832  |  38
Drug Image file DrugItem_2833.JPG
Oxybutynin 5mg Tab
Mylan Institutional LLC formerly UDL Laboratories Inc
Pill Identification: 832  |  38
Drug Image file DrugItem_14014.JPG
Oxybutynin 5mg Tab
American Health Packaging
Pill Identification: 4853 V 
Drug Image file DrugItem_6476.JPG
Ditropan 5mg Tab
Janssen Pharmaceuticals, Inc, formerly Ortho Womens Health & Urology, Division of
Pill Identification: DITROPAN  |  92 00
Drug Image file DrugItem_1839.JPG
Oxybutynin 5mg Tab
Actavis Inc. formerly Watson Pharmaceuticals Inc
Pill Identification: WATSON 779 
Drug Image file DrugItem_2129.JPG
Oxybutynin 5mg Tab
Pliva Inc a Division of Teva USA
Pill Identification: PLIVA 456 
Drug Image file DrugItem_1418.JPG
Oxybutynin 5mg Tab
Actavis Inc. formerly Watson Pharmaceuticals Inc
Pill Identification: WATSON 779 
Drug Image file DrugItem_11797.JPG
Oxybutynin 5mg Tab
PD-RX Pharmaceuticals Incorporated
Pill Identification: 4853 V 
Drug Image file DrugItem_2710.JPG
Oxybutynin 5mg Tab
Qualitest Pharmaceuticals Inc
Pill Identification: 4853 V 
Drug Image file DrugItem_1025.JPG
Oxybutynin 5mg Tab
Major Pharmaceuticals Inc
Pill Identification: PLIVA 456 
Drug Image file DrugItem_8327.JPG
Oxybutynin 5mg Tab
Akyma Pharmaceuticals
Pill Identification: PLIVA 456 

What is this Medicine?

OXYBUTYNIN (ox i BYOO ti nin) is used to treat overactive bladder. This medicine reduces the amount of bathroom visits. It may also help to control wetting accidents.

Similar Generic Drugs : Oxybutynin: Oral tablet (5mg)
In-Depth Information
Select a Medication

Ditropan 5mg Tablet

NDC: 173149200
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Neurogenic Bladder, Urinary Incontinence, Overactive Bladder (OAB)

Storage Information
Store at room temperature (between 59 to 86 degrees F)
Ditropan 5mg Tablet
Drug Image file DrugItem_6476.JPG
Janssen Pharmaceuticals, Inc, formerly Ortho Womens Health & Urology, Division of
Pill Identification: DITROPAN  |  92 00
Shape: round
Color: blue

Reported Side Effects for Ditropan 5mg Tablet

Excessive Thirst Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Blurred Vision Incidence:
1.0-9.6%*
Severity: MODERATE
Onset: EARLY
Breathing Difficulties Incidence:
1.0-4.9%*
Severity: SEVERE
Onset: RAPID
Confusion Incidence:
1.0-4.9%*
Severity: MODERATE
Onset: EARLY
Metallic Taste Incidence:
1.0-4.9%*
Severity: MILD
Onset: EARLY
Belching Incidence:
1.0-4.9%*
Severity: MILD
Onset: EARLY
Back Pain Incidence:
1.0-4.9%*
Severity: MODERATE
Onset: DELAYED
Fluid Retention Incidence:
1.0-4.9%*
Severity: MODERATE
Onset: DELAYED
Flushing Incidence:
1.0-4.9%*
Severity: MILD
Onset: RAPID
Heartburn Incidence:
1.0%*
Severity: MILD
Onset: DELAYED
Hoarseness Incidence:
1.0-4.9%*
Severity: MILD
Onset: EARLY
Loose Stools Incidence:
1.0-7.9%*
Severity: MILD
Onset: EARLY
Increased Urination Incidence:
1.0-4.9%*
Severity: MILD
Onset: EARLY
Bladder Infection Incidence:
1.0-4.9%*
Severity: MODERATE
Onset: DELAYED
Dry Nose Incidence:
1.0-4.9%*
Severity: MILD
Onset: EARLY
Eye Irritation Incidence:
1.0-4.9%*
Severity: MILD
Onset: RAPID
Rapid Heart Rate Incidence:
1.0-4.9%*
Severity: MODERATE
Onset: EARLY
Cough Incidence:
1.0-4.9%*
Severity: MILD
Onset: DELAYED
Rapid Heart Rate Incidence:
1.0-4.9%*
Severity: MODERATE
Onset: RAPID
Joint Pain Incidence:
1.0-4.9%*
Severity: MILD
Onset: DELAYED
Stuffy Nose Incidence:
1.0-4.9%*
Severity: MILD
Onset: EARLY
Inflamed Eye Incidence:
1.0-4.9%*
Severity: SEVERE
Onset: EARLY
Sore Throat Incidence:
1.0-4.9%*
Severity: MILD
Onset: DELAYED
Itching Incidence:
1.0-4.9%*
Severity: MILD
Onset: RAPID
Hives Incidence:
1.0-4.9%*
Severity: MILD
Onset: RAPID
Dry Eyes Incidence:
1.0-3.1%*
Severity: MILD
Onset: EARLY
Dry Skin Incidence:
1.0-4.9%*
Severity: MILD
Onset: DELAYED
Stomach Pain Incidence:
1.0-4.9%*
Severity: MILD
Onset: EARLY
Difficulty Swallowing Incidence:
1.0-4.9%*
Severity: MODERATE
Onset: DELAYED
Increased Blood Sugar Incidence:
1.0-4.9%*
Severity: MODERATE
Onset: DELAYED
Infection Incidence:
1.0-5.4%*
Severity: MILD
Onset: DELAYED
Back Pain Incidence:
1.0-4.9%*
Severity: MILD
Onset: DELAYED
Weakness Incidence:
1.0-4.9%*
Severity: MILD
Onset: DELAYED
Painful Urination Incidence:
1.0-4.9%*
Severity: MODERATE
Onset: EARLY
Swelling Incidence:
1.0-4.9%*
Severity: MODERATE
Onset: DELAYED
Vomiting Incidence:
1.0-4.9%*
Severity: MILD
Onset: EARLY
Gas Incidence:
1.0-4.9%*
Severity: MILD
Onset: EARLY
Fluid Retention Incidence:
1.0-4.9%*
Severity: MODERATE
Onset: DELAYED
Retaining Urine Incidence:
1.2-6.0%*
Severity: MODERATE
Onset: EARLY
Constipation Incidence:
1.3-15.1%*
Severity: MODERATE
Onset: DELAYED
Headache Incidence:
1.5-7.5%*
Severity: MILD
Onset: EARLY
Lightheadedness Incidence:
2.8-16.6%*
Severity: MILD
Onset: EARLY
Inability To Sleep Incidence:
3.0-5.5%*
Severity: MILD
Onset: EARLY
Skin Rash Incidence:
3.3%*
Severity: MILD
Onset: EARLY
Dry Mouth Incidence:
4.1-71.4%*
Severity: MILD
Onset: EARLY
Upset Stomach Incidence:
4.5-6.0%*
Severity: MILD
Onset: EARLY
Upset Stomach Incidence:
4.5-11.6%*
Severity: MILD
Onset: EARLY
Drowsiness Incidence:
5.6-14.0%*
Severity: MILD
Onset: EARLY
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Daily Life Interactions for Ditropan 5mg Tablet

Elements of your daily lifestyle may have an effect on the medications you are taking. Drug interactions can result in unwanted side effects, reduce the effectiveness of your medicine or possibly increase the action of a particular medicine.

Moderate Lifestyle Interaction
Grapefruit juice and Ditropan 5mg Tablet(Oxybutynin Chloride)
Grapefruit juice and Oxybutynin(Oxybutynin Chloride)
Grapefruit juice and grapefruit-containing foods may increase the side effects of Oxybutynin. Do not significantly increase grapefruit juice intake while taking this drug, or avoid grapefruit juice if possible. Discuss any new or worsening side effects, such as confusion, constipation, dizziness, difficulty with urination, drowsiness, dry mouth and eyes, changes in vision, palpitations, or fast heartbeat with your health care provider. Do not drive or operate machinery until you know how these drugs affect you.
Moderate Lifestyle Interaction
Alcohol and Ditropan 5mg Tablet(Oxybutynin Chloride)
Alcohol and Oxybutynin(Oxybutynin Chloride)
Do not drink Alcoholic beverages while taking Oxybutynin (Ditropan). You may feel drowsy or more tired if you drink alcohol-containing drinks while taking Oxybutynin. Do not drive or operate machinery while drinking Alcoholic beverages and until you know how Oxybutynin affects you. You may also notice an increase in the frequency of urination while taking Oxybutynin and drinking alcoholic beverages.
Minor Lifestyle Interaction
Caffeine-containing Foods/Beverages and Ditropan 5mg Tablet(Oxybutynin Chloride)
Caffeine-containing Foods/Beverages and Oxybutynin(Oxybutynin Chloride)
The intake of beverages containing caffeine may decrease the actions of Oxybutynin because Caffeine may increase urination. You may wish to limit your caffeine intake (including intake of coffee, colas, teas, or herbal supplements) while taking oxybutynin.
Pregnancy & Lactation Information
FIRST Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

SECOND Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

THIRD Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

Lactation

Avoid - This drug is known to cause harm to infants when taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Ditropan

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5